Mirae Asset Global Etfs Holdings Ltd. Editas Medicine, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 47,415 shares of EDIT stock, worth $185,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,415
Previous 168,722
71.9%
Holding current value
$185,866
Previous $195,000
46.67%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EDIT
# of Institutions
218Shares Held
45.5MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$30.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$28.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$7.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.36 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.24 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $269M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...